Skip to main content
Download PDF

Turner syndrome and guidelines for management of thoracic aortic disease: Appropriateness and utility

Artery Research volume 15, pages 21–29 (2016)Cite this article

Abstract

Introduction

Current guidelines for management of thoracic aortic disease base clinical decision-making primarily on the aortic size. The risk of serious complications in genetically-triggered aortic disease is influenced by many other factors, currently not taken into account by the guidelines.

Methods

An extensive review of the medical literature using PubMed and Medline.

Results

Current guidelines do not make a distinction between atherosclerotic and nonatherosclerotic aneurysmal disease. Current guidelines for genetically triggered thoracic aortic disease are based on data from Marfan syndrome population. There remain significant differences between Turner syndrome and Marfan syndrome (in patient gender, fertility, stature, female sex hormone and growth hormone therapy as well as presence of coarctation) may have influence on the natural history of the disease and risk assessment.

Conclusions

Turner syndrome patients have a distinct set of factors influencing the development and natural history of their aortic disease, as opposed to Marfan syndrome patients. Therefore, a different set of clinical, genetic and biomarker parameters need to be devised for this condition. Recommendations from the current guidelines need further updates to better address indications for surveillance and therapeutic interventions in patients with Turner syndrome.

References

  1. Hiratzka L, Bakris G, Beckman J, Bersin R, Carr V, Casey D, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine WRITING GROUP MEMBERS. Circulation 2010;121: e266–369. http://doi.org/10.1161/CIR.0b013e3181d4739e. published online before print March 16 2010.

  2. Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, et al. Diagnosis and management of aortic dissection. Recommendations of the Task Force on Aortic Dissection, European Society of Cardiology. Eur Heart J 2001;22:1642–81.

    Google Scholar 

  3. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014 Nov 1;35(41):2873–926. http://doi.org/10.1093/eurheartj/ehu281. Epub 2014 Aug 29.

  4. JP1 Maureira, Vanhuyse F, Lekehal M, Hubert T, Vigouroux C, Mattei MF, et al. Failure of Marfan anatomic criteria to predict risk of aortic dissection in Turner syndrome: necessity of specific adjusted risk thresholds. Interact Cardiovasc Thorac Surg 2012 May;14(5):610–4. http://doi.org/10.1093/icvts/ivr172. Epub 2012 Jan 26.

  5. Gravholt C. Prenatal and postnatal prevalence of Turner’s syndrome: a registry study. BMJ 1996;312:16–21.

    Google Scholar 

  6. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, on behalf of the United Kingdom Clinical Cytogenetics Group. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008a;93:4735–42.

    Google Scholar 

  7. Buckway C, Magenis R, Bissonnette J, Olson S, Rosenfeld R. Prenatal diagnosis of Turner syndrome: the Portland experience. In: Saenger P, Pasquino A, editors. 5th International Turner Symposium-optimizing health care for Turner patients in the 21st century. Amsterdam, the Netherlands: Elsevier; 2000. p. 69–76.

    Google Scholar 

  8. Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, et al. Trends in age at diagnosis of Turner syndrome. Arch Dis Child 2005;90(3):267–8.

    Google Scholar 

  9. Morgan T. Turner syndrome: diagnosis and management. Am Fam Physician 2007;76:5405–10.

    Google Scholar 

  10. Gunther D, Eugester E, Zagar A, Bryant C, Davenport M, Quigley C. Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics 2004;114(3):640–4.

    Google Scholar 

  11. Stochholm K, Juul S, Juel K, Naeraa R, Gravholt C. Prevalence, incidence, diagnostic delay and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897–920.

    Google Scholar 

  12. Savendahl I, Davenport M. Delayed diagnosis of Turner’s syndrome: proposed guidelines for change. J Pediatr 2000;137: 455–9.

    Google Scholar 

  13. Zhong Q, Layman L. Genetic considerations in the patient with Turner syndrome–45,X with or without mosaicism. Fertil Steril 2012 Oct;98(4):775–9. http://doi.org/10.1016/j.fertnstert. 2012.08.021.

  14. Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner’s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983;64:24–7.

    Google Scholar 

  15. Surerus E, Huggon IC, Allan LD. Turner’s syndrome in fetal life. Ultrasound Obstet Gynecol 2003;22:264–7.

    Google Scholar 

  16. Iyer NP, Tucker DF, Roberts SH, Moselhi M, Morgan M, Matthes JW. Outcome of fetuses with Turner syndrome: a 10-year congenital anomaly register based study. J Matern Fetal Neonatal Med 2012 Jan;25(1):68–73. http://doi.org/10.3109/14767058.2011.564688. Epub 2011 Apr 4.

    Google Scholar 

  17. Koeberl D, McGillivray B, Sybert V. Prenatal diagnosis of 45,X/46,XX mosaicism and 45,X: implications for postnatal outcome. Am J Hum Genet 1995;57(3):661–6.

    Google Scholar 

  18. Huber C, Rosilio M, Munnich A, Cormier-Daire V. High incidence of SHOX anomalies in individuals with short stature. J Med Genet 2006;43:735–9.

    Google Scholar 

  19. Ogata T, Fukami M. Clinical features in SHOX haploinsufficiency: diagnostic and therapeutic implications. GGH 2004;20(2):17–23.

    Google Scholar 

  20. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000;9:695–702.

    Google Scholar 

  21. Oliveira C, Alves C. The role of the SHOX gene in the pathophysiology of Turner syndrome. Endocrinol Nutr 2011 Oct 16; 58(8):433–42. Epub 2011 Sep 16.

    Google Scholar 

  22. Byers PH. The Marfan syndrome-TGF-b connection. GGH 2004; 20:60–1.

    Google Scholar 

  23. Loeys B, Schwarze U, Holm T, Callewaert B, Thomas G, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-ß receptor. N Engl J Med 2006;355:788–98.

    Google Scholar 

  24. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J Clin Endocrinol Metab 2002;87: 2798–808.

    Google Scholar 

  25. Munns CJ, Haase HR, Crowther LM, Hayes M, Blaschke R, Rappold G, et al. Expression of SHOX in human fetal and childhood growth plate. J Clin Endocrinol Metab 2004;89: 4130–5.

    Google Scholar 

  26. Aza-Carmona M, Shears DJ, Yuste-Checa P, Barca-Tierno V, Hisado-Oliva A, Belinchón A, et al. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer. Hum Mol Genet 2011;20:1547–59.

    Google Scholar 

  27. Ari M, Bakalov VK, Hill S, Bondy CA. The effects of growth hormone treatment on bone mineral density and body composition in girls with Turner syndrome. J Clin Endocrinol Metab 2006;91:4302–5.

    Google Scholar 

  28. Soucek O, Lebl J, Snajderova M, Kolouskova S, Rocek M, Hlavka Z, et al. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin Endocrinol 2011;74:445–52. http://doi.org/10.1111/j.1365-2265.2010.03955.x.

  29. Soucek O, Zapletalova J, Zemkova D, Snajderova M, Novotna D, Hirschfeldova K, et al. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab 2013;98: E1241–7.

    Google Scholar 

  30. Gravholt CH, Naeraa RW. Reference values for body proportions and body composition in adult women with Turner’s syndrome. Am J Med Genet 1997;72:403–8.

    Google Scholar 

  31. Gravholt CH, Hjerrild BE, Naeraa RW, Engbaek F, Mosekilde L, Christiansen JS. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Clin Endocrinol 2005;62:616–22.

    Google Scholar 

  32. Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT. Importance of estrogen on bone health in turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 2004;89:193–9.

    Google Scholar 

  33. Ho V, Bakalov V, Cooley M, Van P, Hood M, Burklow T, et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004; 110:1694–700.

    Google Scholar 

  34. Kappetein AP, Gittenberger-de Groot AC, Zwinderman AH, Rohmer J,Poelmann RE, Huysmans HA. The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. J Thorac Cardiovasc Surg 1991;102: 830–6.

    Google Scholar 

  35. Ostberg JE, Brookes JA, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89:5966–71.

    Google Scholar 

  36. Sybert V. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101(1):E11.

    Google Scholar 

  37. Madriago E, Nguyen T, McFerson M, Larson EV, Airhart N, Moller JH, et al. Frequency and outcomes of cardiac operations and catheter interventions in turner syndrome. Am J Cardiol 2012;110:580–5.

    Google Scholar 

  38. Wong SC, Ehtisham S, Cheung MM, Zacharin M. Cardiovascular evaluation in Turner Syndrome: the evidence, the reality and the challenges. Int J Cardiol 2014 May 1;173(2):341–2. http://doi.org/10.1016/j.ijcard.2014.03.031. Epub 2014 Mar 15. No abstract available.

  39. Tadros T, Klein M, Shapira O. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation 2009; 119:880–90.

    Google Scholar 

  40. Miller MJ, Geffner ME, Lippe BM, Itami RM, Kaplan SA, DiSessa TG, et al. Echocardiography reveals a high incidence of bicuspid aortic valve in Turner syndrome. J Pediatr 1983;102: 47–50.

    Google Scholar 

  41. Mortensen KH, Andersen NH, Gravholt CH. Cardiovascular phenotype in Turner syndrome—integrating cardiology, genetics, and endocrinology. Endocr Rev 2012 Oct;33(5): 677–714. http://doi.org/10.1210/er.2011-1059. Epub 2012 Jun 15. Review.

  42. Cramer JW, Bartz PJ, Simpson PM. The spectrum of congenital heart disease and outcomes after surgical repair among children with Turner’s syndrome: a single-center review. Pediatr Cardiol 2014;35(2):253–60.

    Google Scholar 

  43. Miyabara S, Nakayama M, Suzumori K. Developmental analysis of cardiovascular system of 45,X fetuses with cystic hygroma. Am J Med Genet 1997;68:135–41.

    Google Scholar 

  44. Hope MD, Hope TA, Crook SES. 4D flow CMR in assessment of valve-related ascending aortic disease. JACC Cardiovasc Imaging 2011;4(7):781–7.

    Google Scholar 

  45. Radetti G, Mazzanti L, Di Somma C, Salerno M, Gottardi E, Capalbo D, et al. Evaluation of function and structure of arterial wall in girls and young women with Turner syndrome. J Endocrinol Invest 2015 Sep;38(9):963–70. http://doi.org/10.1007/s40618-015-0268-9. Epub 2015 Apr 2.

    Google Scholar 

  46. Mortensen KH, Gopalan D, Nørgaard BL, Andersen NH, Gravholt CH. Multimodality cardiac imaging in Turner syndrome. Cardiol Young 2016 Feb 4:1–11.

    Google Scholar 

  47. Mavinkurve M, O’Gorman CS. Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome. BBA Clin 2015 Apr 30;3:304–9. http://doi.org/10.1016/j.bba-cli.2015.04.005. eCollection 2015 Jun. Review.

  48. De Groote K, Devos D, Van Herck K, Demulier L, Buysse W, De Schepper J, et al. Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension. Heart Vessel 2015;30:618–25.

    Google Scholar 

  49. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol 2000;52:363–70.

    Google Scholar 

  50. Gravholt CH, Hansen KW, Erlandsen M, Ebbehøj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 2006;24: 353–60.

    Google Scholar 

  51. Marin A, Weir-McCall JR, Webb DJ, van Beek EJ, Mirsadraee S. Imaging of cardiovascular risk in patients with Turner syndrome. Clin Radiol 2015 Aug;70(8):803–14.

    Google Scholar 

  52. L1 Lanzarini, Larizza D, Prete G, Calcaterra V, Meloni G, Sammarchi L, et al. Aortic dimensions in Turner’s syndrome: two-dimensional echocardiography versus magnetic resonance imaging. J Cardiovasc Med Hagerst 2007 Jun;8(6): 428–37.

    Google Scholar 

  53. Bondy C. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 2008;3:2–15.

    Google Scholar 

  54. Mazzanti L, Prandstraller D, Picchio F, Cacciari E, the Italian Study Group for Turner Syndrome. Italian Turner syndrome study: cardiac function and complications. In: Saegnger P, Pasquino A, editors. Optimizing health care for Turner patients in the 21st century. Elsevier Science BV; 2000. p. 125–36.

    Google Scholar 

  55. Landin-Wilhelmsen K, Sylvén L, Berntopr K, Karlsson A, Innala E, Ekman B, et al. Swedish cardiac morbidity study in Turner syndrome. The Italian Study Group for Turner syndrome. In: Saegnger P, Pasquino A, editors. Optimizing health care for Turner patients in the 21st century. Elsevier Science BV; 2000. p. 137–44.

    Google Scholar 

  56. Donadille B, Rousseau A, Zenaty D, Cabrol S, Courtillot C, Samara-Boustani D, et al. Cardiovascular findings and management in Turner syndrome: insights from a French cohort. Eur J Endocrinol 2012;167:517–22.

    Google Scholar 

  57. Boissonnas CC, Davy C, Bornes M, Arnaout L, Meune C, Tsatsatris V, Mignon A, et al. Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil Steril 2009;91:929.e925–7.

    Google Scholar 

  58. Bondy C. Pregnancy and cardiovascular risk for women with Turner syndrome. Womens Health Lond Engl 2014 Jul;10(4): 469–76. http://doi.org/10.2217/whe.14.34. Review.

  59. Kriksciuniene R, Ostrauskas R, Zilaitiene B. Aortopathies in Turner syndrome—new strategies for evaluation and treatment. Endokrynol Pol 2015;66(1):58–65. http://doi.org/10.5603/EP.2015.0010.

    Google Scholar 

  60. Karnis MF. Catastrophic consequences of assisted reproduction: the case of Turner syndrome. Semin Reprod Med 2012;30: 116–22.

    Google Scholar 

  61. Karnis MF. Fertility, pregnancy and medical management of Turner syndrome in the reproductive years. Fertil Steril 2012; 98:787–91.

    Google Scholar 

  62. Hagman A, Källén K, Bryman I, Landin-Wilhelmsen K, Barrenas M, Wennerholm U. Morbidity and mortality after childbirth in women with Turner karyotype. Hum Reprod 2013; 28(7):1961–73.

    Google Scholar 

  63. Birdshall M, Kennedy S. The risk of aortic dissection in women with Turner syndrome. Letter to the editor. Hum Reprod 1996; 11(7):1587. http://doi.org/10.1093/oxfordjournals.humrep.a019445.

  64. Hamilton J, Hozjan I, editors. Turner syndrome: across the lifespan. The Turner Syndrome Society of Canada; 2014.

  65. Bondy C, Van P, Bakalov V, Ho V. Effects of growth hormone treatment on aortic diameter in Turner syndrome. Nat Rev Endocrinol June 2006;2:360. http://doi.org/10.1038/cpendmet0203.

  66. Park E. Body shape in Turner’s syndrome. Hum Biol 1977;49: 215–23.

    Google Scholar 

  67. Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J, et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 2006 Oct;155(4):583–92.

    Google Scholar 

  68. Ostberg JE, Thomas EL, Hamilton G, Attar MJ, Bell JD, Conway GS. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metabolism 2005;90:2631–5.

    Google Scholar 

  69. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, et al. Insulin resistance: an early metabolic defect of Turner’s syndrome. J Clin Endocrinol Metabolism 1991;72: 832–6.

    Google Scholar 

  70. Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G. Characteristics of insulin resistance in Turner syndrome. Diabetes Metab 1990;16:267–71.

    Google Scholar 

  71. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24: 278–301.

    Google Scholar 

  72. Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS. Adipokine dysregulation in Turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab 2005;90:2948–53.

    Google Scholar 

  73. Gravholt CH, Naeraa RW, Nyholm B, Gerdes U, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner syndrome: the impact of sex hormone replacement. Diabetes Care 1998;21: 1062–70.

    Google Scholar 

  74. Sundt T. Indications for ascending aortic replacement in patients with a BAV. In: Presentation at the 3rd Thoracic Aortic Disease Summit. Baltimore, Md. July 9–10th; 2014.

    Google Scholar 

  75. De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, T’sjoen G, et al. Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and management. J Hypertens 2015;33:1342–51.

    Google Scholar 

  76. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010;95:1487–95.

    Google Scholar 

  77. Tancredi G, Versacci P, Pasquino AM, Vittucci AC, Pucarelli I, Cappa M, et al. Cardiopulmonary response to exercise and cardiac assessment in patients with Turner syndrome. Am J Cardiol 2011;107:1076–82.

    Google Scholar 

  78. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl):555–76.

    Google Scholar 

  79. Delbaere A, Englert Y. Turner’s syndrome and oocyte donation. Gynecol Obstet Fertil 2002;30:970–8.

    Google Scholar 

  80. Silberbach M. Susceptibility to aortic dissection in Turner syndrome pregnancy: inadequacy of ASRM Practice Committee Report. Letter to the editor. Fertil Steril 2009;91(5):e33.

    Google Scholar 

  81. Nagel T, Tesch L. ART and high risk patients! Fertil Steril 1997; 68:748–9.

    Google Scholar 

  82. Boissonnas C, Davy C, Bornes M, Arnaout L, Meune C, Tsatsatris V, et al. Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil Steril March 2009;91(3):929.e5–7.

  83. Bodri D, Vernaeve V, Figueras F, Vidal R, Guillén J, Coll O. Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Hum Reprod 2006;21:829–32.

    Google Scholar 

  84. Reindollar R. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2005;83:1074.

    Google Scholar 

  85. Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2006;86(5 Suppl):S127–8.

    Google Scholar 

  86. Turner H. Syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology 1938;23:566–74.

    Google Scholar 

  87. Ullrich O. Uber typische kombinationsbilder multipler abartungen. Z Kinderheilkd 1930;49:271–6.

    Google Scholar 

  88. Conway G. The impact and management of Turner’s syndrome in adult life. Best Pract Res Clin Endocrinol Metab 2002 Jun; 16(2):243–61.

    Google Scholar 

  89. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147–58.

    Google Scholar 

  90. Castelo-Branco C. Management of Turner syndrome in adult life and beyond. Maturitas 2014 Dec;79(4):471–5. http://doi.org/10.1016/j.maturitas.2014.08.011. Epub 2014 Sep 26.

  91. Lucaccioni L, Wong S, Smyth A, Lyall H, Dominiczak A, Ahmed S, et al. Turner syndrome-issues to consider for transition to adulthood. Br Med Bull 2015;113:45–58.

    Google Scholar 

  92. Bogin B, Varela-Silva M. Leg length, body proportion and health: a review with a note on beauty. Int J Environ Res Public Health 2010;7:1047–75. http://doi.org/10.3390/ijerph7031047.

  93. Gründl M, Eisenmann-Klein M, Prantl L. Quantifying female body attractiveness by a statistical analysis of body measurements. Plast Reconstr Surg 2009;123:1064–71.

    Google Scholar 

  94. K1 Lagrou, Froidecoeur C, Verlinde F, Craen M, De Schepper J, François I, et al. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome. Horm Res 2006;66(6):277–84. Epub 2006 Aug 11.

    Google Scholar 

  95. Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon JP, Craen M, et al. Health and psychosocial status of patients with turner syndrome after transition to adulthood: the Belgian experience. Horm Res 2004;62(4):161–7. Epub 2004 Aug 5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiac Surgery, Christiana Hospital, Christiana Care Health System, 4755 Ogletown-Stanton Road, Suite 1E50, Newark, DE, USA

    Hisham M. F. Sherif

Authors
  1. Hisham M. F. Sherif
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisham M. F. Sherif.

Rights and permissions

This is an open access article distributed under the CC BY-NC license. https://doi.org/creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sherif, H.M.F. Turner syndrome and guidelines for management of thoracic aortic disease: Appropriateness and utility. Artery Res 15, 21–29 (2016). https://doi.org/10.1016/j.artres.2016.07.001

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.artres.2016.07.001

Keywords

Artery Research

ISSN: 1876-4401

Contact us